This cluster of papers focuses on the role of erythropoietin and its derivatives in the treatment and management of various diseases, including anemia, chronic kidney disease, heart failure, stroke, and cancer. It explores the use of erythropoiesis-stimulating agents, neuroprotective effects, and the impact on hypoxia-inducible factors. Additionally, it addresses the association with iron deficiency and cardiovascular disease.